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We report transmission of tick-borne encephalitis virus 
(TBEV) in July 2008 through nonpasteurized goat milk to 6 
humans and 4 domestic pigs in an alpine pasture 1,500 m 
above sea level. This outbreak indicates the emergence of 
ticks and TBEV at increasing altitudes in central Europe and 
the efficiency of oral transmission of TBEV.
T
ick-borne  encephalitis  virus  (TBEV)  is  a  human 
pathogenic flavivirus that is endemic to many Euro-
pean countries and to parts of central and eastern Asia (1). 
Even though vaccination can effectively prevent TBE (2), 
>10,000 cases are reported annually for hospitalized per-
sons in areas of Europe and Asia to which TBE is endemic. 
TBEV occurs in natural foci characterized by ecologic hab-
itats favorable for ticks, especially in wooded areas within 
the 7°C isotherm (3). The major route of virus transmission 
is tick bites, but TBEV also can be transmitted during con-
sumption of nonpasteurized milk and milk products from 
infected animals, primarily goats (3). Outbreaks resulting 
from oral virus transmission are rare in central Europe but 
more common in eastern Europe and the Baltic states (3). 
Our investigation of TBEV transmitted by milk from a goat 
in an alpine pasture in a mountainous region provides evi-
dence for a changing TBEV epidemiology in central Europe 
and the expansion of ticks and TBEV to higher regions.
The Study
We investigated a TBE outbreak, comprising 6 cases, 
in a mountain region in western Austria in July 2008. The 
index case occurred in a 43-year-old shepherd who had 
stayed for 24 days at his alpine pasture (1,564 m above sea 
level) before he was hospitalized for nonbacterial urethritis 
and nonspecific influenza-like symptoms (including pain in 
the lower abdomen and legs), followed by clinical signs 
of meningitis. TBEV infection was confirmed serologically 
by ELISA demonstration of specific immunoglobulin (Ig) 
M and IgG in serum and cerebrospinal fluid. The patient 
did not remember a tick bite but had eaten self-made cheese 
prepared from a mixture of nonpasteurized goat milk and 
cow milk 8–11 days before illness onset; further investiga-
tion found 6 additional persons who had eaten the same 
cheese (Figure). For 5 of them, recent TBEV infection was 
serologically proven (Table). For 3 of these persons (2 men, 
44 and 65 years of age; and 1 woman, 60 years of age), 
similar to the index patient, a typical biphasic course and 
symptoms of TBE (nonspecific flu-like symptoms followed 
by fever, cephalea, meningism, and ataxia after 4–10 days) 
developed and they were hospitalized. The 2 other persons 
who had eaten the cheese (female, 37 and 7 years of age) 
were clinically asymptomatic. The noninfected person had 
vomited shortly after eating the cheese because of a gastric 
banding. None of the infected persons had been vaccinated 
against TBEV.
The cheese was prepared from a mixture of fresh milk 
from 1 goat and 3 cows and was eaten shortly after produc-
tion. Detection of TBEV-specific hemagglutination inhib-
iting (HI) and neutralizing antibodies in the goat’s serum 
proved infection in the goat; the 3 cows were seronega-
tive for TBEV. At the time of this investigation (1 month 
after cheese production), TBEV was already undetectable 
by PCR in serum and milk of the goat. Cheese from the 3 
batches produced after the contaminated batch was TBEV 
negative by PCR. The original cheese was no longer avail-
able for testing.
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Figure.  Time  course  and  series  of  events  of  a  tick-borne 
encephalitis  (TBE)  outbreak  from  cheese  made  with  goat  milk. 
Week 0, transport of goat to high altitude; ►, onset of disease;   
O—I, hospitalization period; TBEV, tick-borne encephalitis virus; 
ME, meningoencephalitis.The 4 domestic pigs kept at the alpine pasture and fed 
with the whey and goat milk, however, were seropositive 
(TBEV HI- and neutralizing antibodies detected), which 
indicated TBEV infection, but no clinical signs were ob-
served. Infection with TBEV has been reported in wild 
boars (4,5). Serum samples from 105 goats from pastures 
in the neighborhood also were investigated for TBEV-spe-
cific antibodies; all goats were seronegative.
Conclusions
Our analyses showed that the 6 humans and the 4 pigs 
were infected through the milk of 1 goat, which had been 
transported by car from a TBE–nonendemic valley to the 
alp 12 days before production of the TBEV-contaminated 
cheese. Experiments have demonstrated that infected do-
mestic animals (i.e., goats, sheep, and cows) can excrete 
TBEV into milk for ≈3–7 days, beginning as early as the 
second or third day postinfection (6–9). In addition, al-
though cheese was produced once or twice each week, only 
this ≈1-kg batch of cheese transmitted TBEV. Therefore, 
all the evidence indicates that the goat was infected at the 
alpine pasture at an altitude of 1,564 m. Indeed, some ticks 
were collected from cows that had stayed at this altitude 
during the entire summer. Analyses of these ticks for TBEV 
by PCR, however, yielded only negative results.
Our findings provide further evidence for the expan-
sion of TBEV-endemic regions to higher altitudes in cen-
tral Europe. For example, longitudinal studies in the Czech 
Republic, a country with similar climatic and ecologic con-
ditions to those of Austria, showed a shift in Ixodes ricinus 
ticks and TBEV, from 700 m in 1981–1983 to 1,100 m al-
titude in 2001–2005 (10,11). Likewise, Zeman and Beneš 
demonstrated that the maximum altitude at which TBEV 
is found in the Czech Republic gradually moved upward 
during 1970–2000, corresponding to the rise in tempera-
ture during the same period (12). In Scandinavia, a north-
ward extension of the geographic range of I. ricinus ticks 
and TBEV since the mid-1980s has also been recognized 
(1,13–15). Climatic changes most likely are the major driv-
ing forces for the geographic changes in the distribution of 
TBEV and its main vector, I. ricinus, in Europe.
This  report  also  emphasizes  the  efficiency  of  oral 
transmission of TBEV to humans and to pigs. Six of the 7 
persons who ate the cheese and all 4 pigs fed residual milk 
or whey from the same cheese became infected. Given the 
excellent effectiveness of the TBE vaccine (2), vaccination 
probably could have prevented all 6 human cases.
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Table. Infection parameters of 7 persons exposed to TBEV by eating nonpasteurized goat cheese, Austria, 2008* 
Virologic parameters 
TBEV ELISA  Sex/ 
age, y 
Incubation,
d Symptoms/signs  Diagnosis
Hospitalized,
d Material IgM IgG
TBEV
NT
TBEV
infection
confirmed
Serum Pos Pos Pos M/43 11 Fever, cephalea, meningism, 
aseptic urethritis; CSF: 
pleocytosis 
ME 18
CSF Bor Pos
Yes 
Serum Pos Pos Pos M/65 10 Fever, cephalea, meningism, 
vertigo, cerebellar ataxia; CSF: 
pleocytosis 
ME 30
CSF Bor Bor
Yes 
Serum Pos Pos Pos F/60 14 Fever, cephalea, meningism, 
vertigo, cerebellar ataxia; CSF: 
pleocytosis 
ME 25
CSF Pos Pos
Yes 
Serum Pos Pos Pos M/44 9 Fever, cephalea, meningism, 
vertigo, cerebellar ataxia; CSF: 
pleocytosis 
ME 9
CSF Pos Bor
Yes 
F/37 NA None NA 0 Serum Pos Pos Pos Yes 
F/7 NA None NA 0 Serum Pos Pos Pos Yes 
F/45 NA None NA 0 Serum Neg Neg Neg No
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